|
|
2型糖尿病骨质疏松危险因素研究进展
|
Abstract:
2型糖尿病骨质疏松症指2型糖尿病所致的骨质疏松症，主要症状为骨量减少、骨骼组织损伤。本病风险高且影响很大，是近年来的工作重点。该文对两种高血压骨质疏松风险影响的研究进展作出总结，试图对临床工作进行借鉴。
Type 2 diabetes osteoporosis refers to the osteoporosis caused by type 2 diabetes mellitus. The main symptoms are loss of bone mass and damage to bone tissue. This disease has high risk and great influence, which is the focus of work in recent years. This paper summarizes the research progress on the effects of two kinds of hypertension on osteoporosis risk and tries to provide refer-ence for clinical work.
| [1] | 基层医疗机构骨质疏松症诊断和治疗专家共识[J]. 中国骨质疏松杂志, 2021, 27(7): 937-944. |
| [2] | 胡海丽, 等. 2型糖尿病并发骨质疏松症的影响因素分析[J]. 中国现代药物应用, 2019, 13(22): 91-92. |
| [3] | 许慧娴, 李思远, 林杰文, 等. 2型糖尿病合并骨质疏松症患者胰岛素抵抗与骨密度、血糖的相关性分析[J]. 黑龙江医药, 2021, 34(6): 1455-1456. |
| [4] | 潘颖, 等. 金天格胶囊联合唑来膦酸注射液治疗绝经后糖尿病骨质疏松患者的临床观察[J]. 中国药房, 2016, 27(35): 4953-4956. |
| [5] | 周伶俐, 潘玉荣, 刘丽娜. 老年女性2型糖尿病睡眠障碍与骨质疏松相关性研究[J]. 糖尿病新世界, 2017, 20(10): 43-44. |
| [6] | Nolan, C.J. and Delghingaro-Augusto, V. (2016) Reversibility of Defects in Proinsulin Processing and Islet β-Cell Failure in Obesity-Related Type 2 Diabetes. Diabetes, 65, 352-354. https://doi.org/10.2337/dbi15-0020 |
| [7] | De Laet, C., et al. (2005) Body Mass Index as a Predictor of Fracture Risk: A Meta-Analysis. Osteoporosis International, 16, 1330-1338. https://doi.org/10.1007/s00198-005-1863-y |
| [8] | Loshin, D. (2013) Chapter 2. Business Problems Suited to Big Data Analytics. In: Loshin, D. and Loshin, D., Eds., Big Data Analytics, Morgan Kaufmann, Boston, 11-19. https://doi.org/10.1016/B978-0-12-417319-4.00002-8 |
| [9] | Prieto-Alhambra, D., et al. (2012) The Association between Fracture and Obesity Is Site-Dependent: A Population-Based Study in Postmenopausal Women. Journal of Bone and Mineral Research, 27, 294-300.
https://doi.org/10.1002/jbmr.1466 |
| [10] | 汪青, 黄昊强, 洪嵘, 陈勇, 陈吉, 林华. 绝经后超重及肥胖女性四肢肌肉/脂肪比与骨质疏松性椎体骨折的相关性: 一项横断面研究[J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15(5): 463-468. |
| [11] | Yang, S. and Shen, X. (2015) Association and Relative Importance of Multiple Obesity Measures with Bone Mineral Density: The National Health and Nutrition Examination Survey 2005-2006. Archives of Osteoporo-sis, 10, 14.
https://doi.org/10.1007/s11657-015-0219-2 |
| [12] | Karen, M.K., et al. (2012) Obesity Increases Precision Errors in Dual-Energy X-Ray Absorptiometry Measurements. Journal of Clinical Densitometry, 15, 209-216. https://doi.org/10.1016/j.jocd.2012.01.002 |
| [13] | Evans, A.L., et al. (2015) Bone Density, Microstructure and Strength in Obese and Normal Weight Men and Women in Younger and Older Adulthood. Journal of Bone and Mineral Research, 30, 920-928.
https://doi.org/10.1002/jbmr.2407 |
| [14] | Sornay-Rendu, E., et al. (2013) In Obese Postmenopausal Women, Bone Microarchitecture and Strength Are Not Commensurate to Greater Body Weight: The Os des Femmes de Lyon (OFELY) Study. Journal of Bone and Mineral Research, 28, 1679-1687. |
| [15] | 鲍根强, 等. 甲状旁腺激素联合降钙素对大鼠骨质疏松性骨折骨生长因子的影响[J]. 中国骨质疏松杂志, 2020, 26(4): 480-484+489. |
| [16] | 王楠. PTH、25(OH)D与2型糖尿病合并骨质疏松的相关性[J]. 中国卫生工程学, 2019, 18(6): 896-898. |
| [17] | Yamamoto, M., et al. (2012) Decreased PTH Levels Accompanied by Low Bone Formation Are Associated with Vertebral Fractures in Postmeno-pausal Women with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism, 97, 1277-1284. https://doi.org/10.1210/jc.2011-2537 |
| [18] | 张宝华, 王健. 福善美治疗绝经后骨质疏松症30例[J]. 实用医学杂志, 2009, 25(3): 452-453. |
| [19] | 钟丽华. 密钙息治疗骨质疏松症的疗效[J]. 实用医学杂志, 2009, 25(1): 82. |
| [20] | 刘勇, 何华英. 血钙浓度与骨质疏松的相关性研究[J]. 现代医学, 2011, 39(2): 216-217. |
| [21] | 郝雅斌, 洪旭. 绝经后女性2型糖尿病患者血糖控制与骨密度关系的观察[J]. 中国骨质疏松杂志, 2009, 15(7): 487-489+500. |
| [22] | Yong, E.L. and Logan, S. (2021) Menopausal Osteoporosis: Screening, Prevention and Treatment. Singapore Medical Journal, 62, 159-166. https://doi.org/10.11622/smedj.2021036 |
| [23] | Cheong, W.F., Ji, S., Ca-zenave-Gassiot, A., Thu, W.P.P., Logan, S., Cauley, J., Kramer, M.S. and Yong, E.L. (2021) Predictors of Circulating Vitamin D Levels in Healthy Mid-Life Singaporean Women. Archives of Osteoporosis, 16, 26.
https://doi.org/10.1007/s11657-021-00880-2 |
| [24] | Zhou, Y.J., et al. (2013) Role of Sclerostin in the Bone Loss of Postmenopausal Chinese Women with Type 2 Diabetes. Chinese Medical Sciences Journal, 28, 135-139. https://doi.org/10.1016/S1001-9294(13)60038-3 |
| [25] | 黄庆, 陈承志, 张遵真. 中国成人吸烟与骨密度相关性的Meta分析[J]. 现代预防医学, 2016, 43(3): 475-481. |
| [26] | 黄琼娥, 徐应波. 男性吸烟与骨密度及骨生化指标关系的调查与分析[J]. 医学信息, 2018, 31(1): 110-111. |
| [27] | 童小平, 黄百芬. 25-羟基维生素D检测方法综述[J]. 预防医学, 2018, 30(3): 278-280+283. |
| [28] | 王荣锋, 郁昊, 蒋新建. 老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J]. 陕西医学杂志, 2019, 48(8): 1032-1034+1041. |
| [29] | Vilaca, T., et al. (2020) The Risk of Hip and Non-Vertebral Fractures in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis Update. Bone, 137, Article ID: 115457. https://doi.org/10.1016/j.bone.2020.115457 |
| [30] | Si, Y., et al. (2019) Prevalence of Osteoporo-sis in Patients with Type 2 Diabetes Mellitus in the Chinese Mainland: A Systematic Review and Meta-Analysis. Iranian Journal of Public Health, 48, 1203-1214.
https://doi.org/10.18502/ijph.v48i7.2942 |
| [31] | 贾桠钧. 老年男性2型糖尿病患者骨质疏松调查及与体质量指数、糖化血红蛋白、病程和肾功能关系研究[J]. 中国骨质疏松杂志, 2020, 26(1): 75-78. |
| [32] | Katrine, H., Jakob, S. and Bente, L.L. (2019) Diabetes and Bone. Osteoporosis and Sarcopenia, 5, 29-37.
https://doi.org/10.1016/j.afos.2019.05.001 |
| [33] | 林东平, 等. 中青年2型糖尿病患者血脂与骨密度关系[J]. 中国骨质疏松杂志, 2013, 19(6): 557-560. |
| [34] | 安苗苗, 陈兰兰, 张娇艳, 朱焱, 许海娜, 冉利梅. 中老年体检人群高密度脂蛋白胆固醇与骨密度的关系[J]. 中国预防医学杂志, 2022, 23(8): 601-607. |
